ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $24,000 | -31.4% | 6,877 | +100.6% | 0.00% | -50.0% |
| Q1 2021 | $35,000 | +191.7% | 3,428 | +187.6% | 0.00% | +100.0% |
| Q3 2020 | $12,000 | -80.6% | 1,192 | -59.6% | 0.00% | -75.0% |
| Q2 2020 | $62,000 | +287.5% | 2,947 | +79.8% | 0.00% | +300.0% |
| Q1 2020 | $16,000 | +14.3% | 1,639 | +46.1% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | 0.0% | 1,122 | -57.3% | 0.00% | 0.0% |
| Q3 2019 | $14,000 | -89.0% | 2,629 | -75.4% | 0.00% | -88.9% |
| Q2 2019 | $127,000 | +958.3% | 10,694 | +372.1% | 0.01% | +800.0% |
| Q1 2019 | $12,000 | +33.3% | 2,265 | -24.4% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | +200.0% | 2,997 | +532.3% | 0.00% | – |
| Q3 2018 | $3,000 | -40.0% | 474 | -69.3% | 0.00% | – |
| Q4 2017 | $5,000 | -16.7% | 1,546 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $6,000 | +50.0% | 1,546 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 1,546 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | -66.7% | 1,546 | -62.0% | 0.00% | -100.0% |
| Q4 2016 | $12,000 | – | 4,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |